KA

Kineta, Inc.

0.73 USD
+0.02 (+2.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kineta, Inc. stock is up 45.54% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 22.22% of the previous 8 July’s closed higher than June.

About Kineta, Inc.

Yumanity Therapeutics Inc. engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein.